Paul Segal - Jun 9, 2022 Form 4 Insider Report for Alphatec Holdings, Inc. (ATEC)

Role: 10%+ Owner
Signature: /s/ Paul Segal
Stock symbol: ATEC
Transactions as of: Jun 9, 2022
Transactions value $: $512,126
Form type: 4
Date filed: 6/13/2022, 06:07 AM
Previous filing: Nov 26, 2021
Next filing: Jun 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATEC	Common Stock	Purchase	$511K	+71.1K	+42.47%	$7.18	239K	Jun 9, 2022	Direct	F1
transaction	ATEC	Common Stock	Purchase	$1.42K	+200	+0.08%	$7.10	239K	Jun 10, 2022	Direct
holding	ATEC	Common Stock						8.41M	Jun 9, 2022	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging $7.11 to $7.31, inclusive. The reporting undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2	Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

Content

This price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging $7.11 to $7.31, inclusive. The reporting undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.